These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 28499287)
1. Impact of Eligibility Criteria on Participant Enrollment for a Randomized Clinical Trial of Gonorrhea Treatment. Long JE; Wierzbicki MR; Hook EW Sex Transm Dis; 2017 Jun; 44(6):362-364. PubMed ID: 28499287 [TBL] [Abstract][Full Text] [Related]
2. Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollment. Filion M; Forget G; Brochu O; Provencher L; Desbiens C; Doyle C; Poirier B; DuRocher M; Camden S; Lemieux J Clin Trials; 2012 Oct; 9(5):652-9. PubMed ID: 23060323 [TBL] [Abstract][Full Text] [Related]
3. Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials. Logan JK; Tang C; Liao Z; Lee JJ; Heymach JV; Swisher SG; Welsh JW; Zhang J; Lin SH; Gomez DR Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):770-777. PubMed ID: 28244413 [TBL] [Abstract][Full Text] [Related]
4. Patient Eligibility for Randomized Controlled Trials in Critical Care Medicine: An International Two-Center Observational Study. Ivie RM; Vail EA; Wunsch H; Goldklang MP; Fowler R; Moitra VK Crit Care Med; 2017 Feb; 45(2):216-224. PubMed ID: 27779514 [TBL] [Abstract][Full Text] [Related]
5. Benefit-cost analysis of screening. A comparison of tests for gonorrhea. Goddeeris JH; Bronken TP Med Care; 1985 Nov; 23(11):1242-55. PubMed ID: 3934472 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and cost-effectiveness of an automated screening algorithm in an inpatient clinical trial. Beauharnais CC; Larkin ME; Zai AH; Boykin EC; Luttrell J; Wexler DJ Clin Trials; 2012 Apr; 9(2):198-203. PubMed ID: 22308560 [TBL] [Abstract][Full Text] [Related]
7. Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). Greene SJ; Hernandez AF; Sun JL; Metra M; Butler J; Ambrosy AP; Ezekowitz JA; Starling RC; Teerlink JR; Schulte PJ; Voors AA; Armstrong PW; O'Connor CM; Mentz RJ Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623769 [TBL] [Abstract][Full Text] [Related]
8. Centralizing prescreening data collection to inform data-driven approaches to clinical trial recruitment. Kirn DR; Grill JD; Aisen P; Ernstrom K; Gale S; Heidebrink J; Jicha G; Jimenez-Maggiora G; Johnson L; Peskind E; McCann K; Shaffer E; Sultzer D; Wang S; Sperling R; Raman R Alzheimers Res Ther; 2023 May; 15(1):88. PubMed ID: 37131229 [TBL] [Abstract][Full Text] [Related]
9. Factors that influence the cost effectiveness of gonorrhea screening in emergency departments. Gift TL; Irwin KL Sex Transm Dis; 2005 Jul; 32(7):437-8. PubMed ID: 15976601 [No Abstract] [Full Text] [Related]
10. Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols. Gandhi M; Ameli N; Bacchetti P; Sharp GB; French AL; Young M; Gange SJ; Anastos K; Holman S; Levine A; Greenblatt RM AIDS; 2005 Nov; 19(16):1885-96. PubMed ID: 16227797 [TBL] [Abstract][Full Text] [Related]
11. The cost effectiveness of gonorrhea screening in urban emergency departments. Aledort JE; Hook EW; Weinstein MC; Goldie SJ Sex Transm Dis; 2005 Jul; 32(7):425-36. PubMed ID: 15976600 [TBL] [Abstract][Full Text] [Related]
12. Screening and enrolling subjects in a randomized clinical trial involving implant dentures. Walton JN; MacEntee MI Int J Prosthodont; 2008; 21(3):210-4. PubMed ID: 18548957 [TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial. Mason J; Axon AT; Forman D; Duffett S; Drummond M; Crocombe W; Feltbower R; Mason S; Brown J; Moayyedi P; Aliment Pharmacol Ther; 2002 Mar; 16(3):559-68. PubMed ID: 11876711 [TBL] [Abstract][Full Text] [Related]
14. Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial. Dew A; Khan S; Babinski C; Michel N; Heffernan M; Stephan S; Jordan N; Jovanovic B; Carney P; Bergan R Clin Trials; 2013 Apr; 10(2):292-9. PubMed ID: 23321266 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of chlamydia and gonorrhea screening criteria: San Francisco sexually transmitted disease clinic: 1997 to 1998. Ciemins EL; Kent CK; Flood J; Klausner JD Sex Transm Dis; 2000 Mar; 27(3):165-7. PubMed ID: 10726651 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of universal screening for chlamydia and gonorrhea in US jails. Kraut-Becher JR; Gift TL; Haddix AC; Irwin KL; Greifinger RB J Urban Health; 2004 Sep; 81(3):453-71. PubMed ID: 15273268 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of screening strategies for Gonorrhea among females in private sector care. Bernstein KT; Mehta SD; Rompalo AM; Erbelding EJ Obstet Gynecol; 2006 Apr; 107(4):813-21. PubMed ID: 16582117 [TBL] [Abstract][Full Text] [Related]
18. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Masoudi FA; Havranek EP; Wolfe P; Gross CP; Rathore SS; Steiner JF; Ordin DL; Krumholz HM Am Heart J; 2003 Aug; 146(2):250-7. PubMed ID: 12891192 [TBL] [Abstract][Full Text] [Related]